Dermapharm Holding SE (DMP) Q3 2024 Earnings Report
CH:DMP Q3 2024 EPS Results
- Actual EPS
- CHF 0.55
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- CHF 0.42
CH:DMP Q3 2024 Revenue Results
- Actual Revenue
- CHF 285.69M
- Expected Revenue
- CHF 271.66M
- Beat/Miss
- Beat by +CHF 14.03M
- YoY Revenue Growth
- +9.54%
Earnings Announcement Details
- Quarter
- Q3 2024
- Date
- 11/14/2024
- Time
- Before Open
- Conference Call
- Thursday, November 14, 2024
CH:DMP Upcoming Earnings
Dermapharm Holding SE's next earnings date is estimated for November 12, 2026, based on past reporting schedules.
Q3 2024 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q3 2024 Earnings Slide Deck
No slide deck is available for this earnings event.
Q3 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
CH:DMP Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 12, 2026 | 2026 (Q3) | ―- | 0.7 | ― | ― |
| Aug 25, 2026 | 2026 (Q2) | 0.430.43 | 0.36 | 20.51% (+0.07) | |
| May 13, 2026 | 2026 (Q1) | ―0.77 | 0.57 | 35.48% (+0.20) | |
| Mar 10, 2026 | 2025 (Q4) | 0.380.66 | 0.35 | 89.47% (+0.31) | |
| Nov 13, 2025 | 2025 (Q3) | ―0.70 | 0.55 | 26.67% (+0.15) | |
| Aug 26, 2025 | 2025 (Q2) | ―0.36 | 0.29 | 21.88% (+0.06) | |
| May 15, 2025 | 2025 (Q1) | ―0.57 | 0.74 | -23.46% (-0.17) | |
| Mar 14, 2025 | 2024 (Q4) | ―0.35 | -0.05 | 860.00% (+0.39) | |
| Nov 14, 2024 | 2024 (Q3) | ―0.55 | 0.42 | 30.43% (+0.13) | |
| Aug 27, 2024 | 2024 (Q2) | ―0.29 | -0.16 | 288.24% (+0.45) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
